Anthroposophic Supportive Treatment in Children With Medulloblastoma Receiving First-line Therapy

Abstract

AM consisting of different combinations of specific pharmacologic and nonpharmacologic interventions seems to be safe with respect to any potential negative impact on the first-line therapy. There is no evidence with regard to tumor enhancement. The effectiveness of the supportive AM cannot be assessed on the basis of these data.